About Us
Meet the Team
Rodrigo Gutierrez
Managing Analyst

Rodrigo is a Managing Analyst in the UK team. He has a wealth of experience in pharmaceutical business intelligence, having previously worked as a consultant advising leading pharmaceutical and medical device companies on a range of technological and strategy issues. He has led and supervised business intelligence projects on a range of technologies and therapeutic areas including CNS, Ophthalmology, Gastrointestinal, Dermatology and medical devices. Rodrigo has a BSc Hons in Pharmacology and Molecular Genetics from King’s College London and an MSc in Biotechnology, Bioprocessing and Business Management from the University of Warwick.

Analyst Views

28 Nov 16
Repurposing Type 2 Diabetes Mellitus Drugs for Alzheimer’s ....
In this Analyst View, Fiona Chisholm, Analyst for GBI Research, discusses the potential f.....
Read post
21 Nov 16
Urological Cancer Treatment Landscape to be Transformed by ....
In this Analyst View, Adam Bradbury, Associate Analyst for GBI Research, discuses current.....
Read post

White Papers

22 Nov 16
An Exploration of Novel and Repositioned Calcium Transport ....
This whitepaper discusses the increasing interest in using repositioned calcium transport....
Read post
14 Nov 16
The Emerging Field of Cannabinoid-Based Products....
This white paper discusses the current commercial landscape for cannabinoid-based product....
Read post

Press Releases

17 Oct 17
Industry pipeline for monoclonal antibodies encompasses ove....
The overall industry pipeline for monoclonal antibodies (mAbs) has reached a unprecedente.....
Read post
13 Oct 17
New Diabetes Therapeutics to Steal Ground from Insulin Ther....
The incidence of diabetes mellitus (DM), and most notably type 2 diabetes mellitus (T2DM).....
Read post